Brazilian Medtechs Leave Gloomy 2021 Far Behind As Exports Hit New High

Brazil's ABIMO medtech industry association reports newly-buoyant levels of export activity, as normal business routines crystalize further in the post-COVID phase. Meanwhile, member companies of the Brazil Health Devices initiative are outperforming industry averages.

BrazilMap_1200x675

Brazilian medtech exports for the first half of 2022 were 13.8% higher than for the same period in 2021. According to an analysis of government data by ABIMO, the national medical devices industry association, total exports for the half year reached US$426.4m.

That alone would be cause for celebration, especially on the back of a 4.9% year-on-year slump in H1 2021. However, apart from a 1.2% contraction in July 2022 (to $74m),...

More from Archive

More from Medtech Insight

Execs On The Move: 5-9 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By 

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.